Results - Use of ffDNA in prenatal diagnosis
There have been numerous publications relating to the work
conducted by Prof Soothill and colleagues, please follow the links
below to find out more:
Attilakos G, Maddocks DG, Davies T, Hunt LP, Avent ND, Soothill
PW, Grant SR. Quantification
of free fetal DNA in multiple pregnancies and
relationship with chorionicity. Prenat Diagn. 2011
Oct;31(10):967-72. doi: 10.1002/pd.2814. Epub 2011 Jul 19.
Illanes S, Parra M, Serra R, Pino K,
Figueroa-Diesel H, Romero C, Arraztoa JA, Michea L, Soothill PW. Increased free
fetal DNA levels in early pregnancy plasma of women who
subsequently develop preeclampsia and intrauterine growth
restriction. Prenat Diagn. 2009 Dec;29(12):1118-22
Maddocks DG, Alberry MS, Attilakos G, Madgett TE,
Choi K, Soothill PW, Avent ND. The SAFE
project: towards non-invasive prenatal diagnosis. Biochem Soc
Trans. 2009 Apr;37(Pt 2):460-5.
Avent ND, Madgett TE, Maddocks DG, Soothill PW. Cell-free
fetal DNA in the maternal serum and plasma: current and
evolving applications. Curr Opin Obstet Gynecol. 2009
Apr;21(2):175-9.
Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt
LP, Abdel-Fattah SA, Avent ND, Soothill PW.Quantification
of cell free fetal DNA in maternal plasma in normal
pregnancies and in pregnancies with placental dysfunction. Am J
Obstet Gynecol. 2009 Jan;200(1):98.e1-6.
Avent ND, Plummer ZE, Madgett TE, Maddocks DG,
Soothill PW. Post-genomics
studies and their application to non-invasive prenatal
diagnosis. Semin Fetal Neonatal Med. 2008 Apr;13(2):91-8.
Alberry MS, Soothill PW.Non-invasive
prenatal diagnosis: implications for antenatal diagnosis and
management of high-risk pregnancies. Semin Fetal Neonatal Med.
2008 Apr;13(2):84-90
Alberry M, Maddocks D, Jones M, Abdel Hadi M,
Abdel-Fattah S, Avent N, Soothill PW. Free
fetal DNA in maternal plasma in anembryonic
pregnancies: confirmation that the origin is the trophoblast.
Prenat Diagn. 2007 May;27(5):415-8.
Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW. Early detection
of cell-free fetal DNA in maternal plasma. Early Hum
Dev. 2007 Sep;83(9):563-6
Illanes S, Denbow ML, Smith RP, Overton TG,
Soothill PW, Finning K. Detection of
cell-free fetal DNA in maternal urine. Prenat Diagn.
2006 Dec;26(13):1216-8.
Smith RP, Lombaard H, Soothill PW. The
obstetrician's view: ethical and societal implications of
non-invasive prenatal diagnosis. Prenat Diagn. 2006
Jul;26(7):631-4.
Illanes S, Avent N, Soothill PW. Cell-free
fetal DNA in maternal plasma: an important advance to
link fetal genetics to obstetric ultrasound. Ultrasound Obstet
Gynecol. 2005 Apr;25(4):317-22.
Bartha JL, Finning K, Soothill PW. Fetal sex
determination from maternal blood at 6 weeks of gestation when at
risk for 21-hydroxylase deficiency. Obstet Gynecol. 2003
May;101(5 Pt 2):1135-6.